Premium
Translational Medicine 2.0: From Clinical Diagnosis–Based to Molecular‐Targeted Therapies in the Era of Globalization
Author(s) -
Albani S,
Colomb J,
Prakken B
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.60
Subject(s) - translational medicine , clinical pharmacology , translational research , outcome (game theory) , clinical practice , field (mathematics) , medicine , engineering ethics , data science , pharmacology , computer science , family medicine , pathology , engineering , economics , mathematical economics , mathematics , pure mathematics
Translational medicine encompasses the itinerary from the conception of an idea to its implementation in the diagnosis, prognosis, and treatment of human diseases. It cannot be identified as a stand‐alone field; rather, it comprises a fragmented patchwork of activities, competencies, and knowledge distributed along diverse and often disparate disciplines. In standard practice, the success of a translational project is often less dependent on the validity of the original idea than on the outcome of the combination of several stochastic events. Clinical Pharmacology & Therapeutics (2010) 87 6, 642–645. doi: 10.1038/clpt.2010.60